Name: UMIN ID:
Unique ID issued by UMIN | UMIN000010334 |
---|---|
Receipt number | R000012097 |
Scientific Title | A phase II trial of early phase eribulin for metastatic breast cancer. |
Date of disclosure of the study information | 2013/04/01 |
Last modified on | 2024/03/21 11:15:27 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2013/03/27 23:29:32 | ||
2 | Update | 2015/06/02 12:48:12 | Last name of lead principal investigator Last name of lead principal investigator TEL Last name of contact person Last name of contact person Address Address Institutions |
|
3 | Update | 2015/11/08 08:40:09 | Name of person sending information Name of person sending information |
|
4 | Update | 2024/03/21 11:15:27 | Recruitment status Date of IRB Last follow-up date |